Nancy A. Simonian

Director, ARQULE INC.

Companies

Generate Biomedicines, Inc.Board member Feb 26, 2026 to now¹
Syros Pharmaceuticals, Inc.Board member Jun 29, 2016 to Dec 4, 2024²
SeagenBoard member Mar 21, 2012 to Dec 15, 2023³
Syros Pharmaceuticals, Inc.Chief executive officer Jun 29, 2016 to Nov 2, 2023²
Syros Pharmaceuticals, Inc.President Jun 29, 2016 to Nov 2, 2023²
Evelo Biosciences, Inc.Board member May 8, 2018 to Jun 18, 2020⁴

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 2, 2024Sold 37,070 shares at $0.27 of Syros Pharmaceuticals, Inc.⁶
Nov 25, 2024Sold 134,713 shares at $0.27 of Syros Pharmaceuticals, Inc.⁷
Oct 31, 2024Exercised options 40,125 shares of Syros Pharmaceuticals, Inc.⁸
Jun 5, 2024Granted 4,000 shares of Syros Pharmaceuticals, Inc.⁹
Apr 1, 2024Shares withheld for tax 14,052 shares at $5.12 of Syros Pharmaceuticals, Inc.¹⁰
Mar 31, 2024Exercised options 39,566 shares of Syros Pharmaceuticals, Inc.¹⁰
Mar 31, 2024Exercised options 6,000 shares of Syros Pharmaceuticals, Inc.¹⁰
Dec 14, 2023Returned to company 62,753 shares at $229.00 of Seagen⁵
Nov 1, 2023Shares withheld for tax 13,401 shares at $2.22 of Syros Pharmaceuticals, Inc.¹¹
Oct 31, 2023Exercised options 40,125 shares of Syros Pharmaceuticals, Inc.¹¹
May 31, 2023Granted 2,044 shares of Seagen¹²
Apr 3, 2023Shares withheld for tax 1,852 shares at $2.58 of Syros Pharmaceuticals, Inc.¹³
Mar 31, 2023Exercised options 6,000 shares of Syros Pharmaceuticals, Inc.¹³
Dec 12, 2022Exercised options 8,750 shares at $36.70 of Seagen¹⁴
May 13, 2022Granted 1,503 shares of Seagen¹⁵
Apr 1, 2022Shares withheld for tax 58,883 shares at $1.12 of Syros Pharmaceuticals, Inc.¹⁶
Mar 2, 2022Exercised options 25,000 shares at $20.04 of Seagen¹⁷

The numbers on this page point here. Each one links to the record it came from.